Along with Herta, Nestlé is also considering selling its skin health units. These two potential sales and the overall uptick in M&A for the company comes as a result of significant pressure to streamline its portfolio to high-growth products. Activist investor Daniel Loeb heavily criticized the company's "muddled" strategy and pushed Nestlé to focus its capital spending on food and beverage categories including coffee, pet care and bottled water.